Skip to content

Somru Bioscience to become global leader in biotech research

Federal investment to expand facility will support high-skilled job growth and strengthen the bioscience sector in PEI. 

For over a decade, a family-owned biotechnology company in Prince Edward Island has been making a name for itself around the globe, developing innovative and affordable pharmaceutical solutions. With Government of Canada support, Somru BioScience Inc. is expanding operations to provide enhanced research and laboratory support for clients developing biotherapeutic treatments.

Innovative Research Services

On February 16, the Honourable Ginette Petitpas Taylor, Minister of Official Languages and Minister responsible for ACOA, announced a total federal investment of $1,950,000, through the Regional Economic Growth through Innovation (REGI) program for two projects with Somru BioScience Inc.

The contribution will help the company launch a contract research services division in Charlottetown, P.E.I. in response to increased market demand in the biologics and biosimilar drug market. With the help of this federal investment, the company will proceed with a 15,000 square foot expansion that will further position the company as a global leader. Along with new, advanced equipment, this will give Somru the capacity to offer large molecule bioanalytical services to pharmaceutical development companies in North America and Europe.

This announcement demonstrates the Government of Canada’s commitment to advance Atlantic Canada’s bioscience sector in a globally competitive market, and attract more highly-skilled workers to the region.

Read more.

Scroll To Top